Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 43,846 |
|
|||||
| News | - | ||||||
| Day High | 13.04 | Low High |
|||||
| Day Low | 12.30 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| GH Research PLC | GHRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.13 | -1.02% | 12.60 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.81 | 12.30 | 13.04 | 12.60 | 12.73 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 575 | 43,846 | $ 12.78 | $ 560,348 | - | 5.05 - 14.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:00:44 | 5 | $ 12.73 | USD |
GH Research PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 646.71M | 52.03M | - | 0 | -35.59M | -0.68 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
GH Research News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GHRS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.12 | 13.35 | 11.99 | 12.86 | 43,550 | 0.48 | 3.96% |
| 1 Month | 11.23 | 13.35 | 10.30 | 11.79 | 54,683 | 1.37 | 12.20% |
| 3 Months | 7.44 | 13.35 | 6.82 | 10.68 | 96,120 | 5.16 | 69.35% |
| 6 Months | 7.28 | 13.35 | 5.05 | 8.39 | 106,519 | 5.32 | 73.08% |
| 1 Year | 10.56 | 14.70 | 5.05 | 9.34 | 91,578 | 2.04 | 19.32% |
| 3 Years | 22.00 | 30.43 | 5.05 | 13.84 | 87,269 | -9.40 | -42.73% |
| 5 Years | 22.00 | 30.43 | 5.05 | 13.84 | 87,269 | -9.40 | -42.73% |
GH Research Description
| GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. |
